True North Advisors, LLC Eli Lilly & CO Transaction History

True North Advisors, LLC

$378 Million
Q3 2024

A detailed history of True North Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, True North Advisors, LLC holds 3,225 shares of LLY stock, worth $2.57 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares

3,225

Previous 3,267 1.29%

Holding current value

$2.57 Million

Previous $2.96 Million 3.38%

% of portfolio

0.76%

Previous 0.79%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$772.14 - $960.02 $32,429 - $40,320	-42 Reduced 1.29%	3,225 $2.86 Million
Q2 2024 Aug 12, 2024	SELL	$724.87 - $909.04 $755,314 - $947,219	-1,042 Reduced 24.18%	3,267 $2.96 Million
Q1 2024 Apr 12, 2024	BUY	$592.2 - $792.28 $10,659 - $14,261	18 Added 0.42%	4,309 $3.35 Million
Q4 2023 Jan 22, 2024	SELL	$525.19 - $619.13 $59,871 - $70,580	-114 Reduced 2.59%	4,291 $2.5 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $469,910 - $647,843	-1,081 Reduced 19.7%	4,405 $2.37 Million
Q2 2023 Aug 10, 2023	BUY	$350.74 - $468.98 $110,833 - $148,197	316 Added 6.11%	5,486 $2.57 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $208,122 - $244,429	670 Added 14.89%	5,170 $1.78 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $40,914 - $46,626	-138 Reduced 2.98%	4,500 $1.46 Million
Q2 2022 Jul 28, 2022	BUY	$278.73 - $327.27 $48,499 - $56,944	174 Added 3.9%	4,638 $1.5 Million
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $177,895 - $221,078	758 Added 20.45%	4,464 $1.28 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $15,289 - $18,974	68 Added 1.87%	3,706 $1.02 Million
Q3 2021 Jun 07, 2022	BUY	$221.6 - $272.71 $9,307 - $11,453	42 Added 1.17%	3,638 $840,000
Q2 2021 Jun 07, 2022	SELL	$180.55 - $233.54 $7,402 - $9,575	-41 Reduced 1.13%	3,596 $825,000
Q1 2021 Jun 07, 2022	BUY	$164.32 - $212.72 $29,906 - $38,715	182 Added 5.27%	3,637 $679,000
Q4 2020 May 20, 2022	SELL	$130.46 - $172.63 $25,178 - $33,317	-193 Reduced 5.29%	3,455 $583,000
Q3 2020 May 20, 2022	BUY	$146.22 - $169.13 $50,592 - $58,518	346 Added 10.48%	3,648 $539,000
Q2 2020 May 20, 2022	BUY	$136.42 - $164.18 $450,458 - $542,122	3,302 New	3,302 $542,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of True North Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True North Advisors, LLC with notifications on news.

Account

True North Advisors, LLC Eli Lilly & CO Transaction History